Michael Gelband’s Scotiabank BNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Buy
+15,801
New +$1.24M 0.01% 973
2026
Q1
Sell
-15,600
Closed -$1.15M 1581
2025
Q4
$1.15M Sell
15,600
-76,222
-83% -$5.18M 0.01% 941
2025
Q3
$5.94M Buy
+91,822
New +$5.41M 0.06% 351
2024
Q4
Sell
-90,786
Closed -$4.95M 1548
2024
Q3
$4.95M Buy
+90,786
New +$4.4M 0.03% 428
2022
Q4
Sell
-4,708
Closed -$224K 1656
2022
Q3
$224K Buy
4,708
+11
+0.2% +$629 ﹤0.01% 1610
2022
Q2
$278K Buy
+4,697
New +$305K ﹤0.01% 1559
2020
Q4
Sell
-28,141
Closed -$1.17M 1977
2020
Q3
$1.17M Buy
+28,141
New +$1.18M 0.02% 616
2019
Q4
Sell
-12,455
Closed -$708K 1542
2019
Q3
$708K Buy
+12,455
New +$669K 0.02% 507

Other funds holding BNS

Michael Gelband's BNS Position: Q2 2026 in Review

Michael Gelband opened a new position in Scotiabank (BNS) in Q2 2026: 15,801 shares worth $1.37M. The stake represents 0.01% of the portfolio and ranks #973 among its holdings. This is a return to the name: Michael Gelband previously reported a position in BNS as recently as Q4 2025.

Michael Gelband first reported a position in BNS in Q3 2019 and has held it in 8 quarters since. The position peaked at $5.94M in Q3 2025. 532 funds tracked by Wall St. Rank hold BNS as of Q2 2026.

  • Michael Gelband held 15,801 shares of Scotiabank worth $1.37M as of Q2 2026.
  • Scotiabank was a new Michael Gelband position in Q2 2026.
  • Scotiabank made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #973 holding.
  • Michael Gelband first reported a position in Scotiabank in Q3 2019 and has held it in 8 quarters since.
  • Michael Gelband's Scotiabank position peaked at $5.94M in Q3 2025.
  • 532 funds tracked by Wall St. Rank held Scotiabank as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.